Madhukar Misra is a Nephrology physician affiliated with University of Missouri. OpenAlex indexes 124 publications with 1,713 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1020 Hitt St
Columbia, MO 652120001
Telephone
573-882-8788Registry record last updated 2 Sept 2022.
Clinical trials
- A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients
Sponsor: University of Missouri-Columbia
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Vantive US Healthcare LLCProgram year20252 payments
- Calliditas Therapeutics US Inc.Program year20252 payments
- Travere Therapeutics, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70%Calcium channel blocker28.1%Nifedipine Er64%Amlodipine Besylate36%Part D<11 patientsAngiotensin receptor blocker (ARB)11.2%Losartan Potassium100%Part D<11 patients+ 5 more classes in this area
Other
18.7%Phosphate Binder18.7%Sevelamer Carbonate100%Part D≥17 patientsBlood & clotting
7.1%Solutions for parenteral nutrition7.1%Calcium Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pseudohyponatremia: Mechanism, Diagnosis, Clinical Associations and Management
Journal of Clinical Medicine
2023 - Mortality Trends After Transfer From Peritoneal Dialysis to Hemodialysis
Kidney International Reports
2022 - Transition between Different Renal Replacement Modalities: Gaps in Knowledge and Care—the Integrated Research Initiative
Peritoneal Dialysis International
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Darian Fard, MD
University of Missouri
Christian G. Brilla
University of Missouri
Michael J. Petris
University of Missouri
Gregory Della Rocca, MD
University of Missouri
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”